Stay updated on ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial
Sign up to get notified when there's something new on the ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial page.

Latest updates to the ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedVersion 11 (2025-11-12) adds Adverse Events, Outcome Measures (Results), Outcome Measures, and Study Status, with a 'Quality Control Review Has Not Concluded' note. The previous revision v3.3.1 was removed from the history.SummaryDifference0.9%

- Check21 days agoChange DetectedThe page history now shows a new revision (v3.3.1) added and an earlier revision (v3.2.0) removed, reflecting an update to the revision log rather than changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedReturned: 2025-11-06 and a new Quality Control Review status are shown, with added sections for Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Document Section, and Study Design/Status.SummaryDifference2%

- Check43 days agoChange DetectedThe Study Record Versions list and version entries appear unchanged between screenshots, indicating no data or functional changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedDifference0.1%

- Check71 days agoChange DetectedUpdated to v3.2.0 and added a government funding/operating-status notice; removed the old v3.1.0 reference.SummaryDifference12%

Stay in the know with updates to ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial page.